36
https://pubmed.ncbi.nlm.nih.gov/38115987
This abstract is a retraction notice for a previous study published in 2020 that investigated the formulation of Aceclofenac tablets using nanosuspension as a granulating agent to enhance dissolution rate and oral bioavailability.